# Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

Study · id `cardio:ct-nct07069738` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07069738](<https://clinicaltrials.gov/study/NCT07069738>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07069738

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

## Technical summary

Registry record NCT07069738. Randomized; single masking; primary purpose treatment. Start 2025-10-22 (actual); primary completion 2029-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 850 participants (planned count; ClinicalTrials.gov record NCT07069738, source copy `cardio:ctgov-nct07069738-2026-11-03`, retrieved 2026-11-18)
- Started: 2025-10-22 (actual) (ClinicalTrials.gov record NCT07069738, source copy `cardio:ctgov-nct07069738-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2029-11 (anticipated) (ClinicalTrials.gov record NCT07069738, source copy `cardio:ctgov-nct07069738-2026-11-03`, retrieved 2026-11-18)
- Completion: 2029-11 (anticipated) (ClinicalTrials.gov record NCT07069738, source copy `cardio:ctgov-nct07069738-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07069738, source copy `cardio:ctgov-nct07069738-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07069738-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Acronym: SYNCHRONICITY
- Condition: Heart Failure - NYHA II - IV
- Intervention (Device): CRT-D with a Quadripolar LV lead
- Intervention (Device): CRT-D with INGEVITY+ pace/sense lead
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: 7d70d4adb4ff503862f8bebe84831eadae39c7284f52c5f4df446de2230e9b79
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
